DK1091750T3 - Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf - Google Patents

Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1091750T3
DK1091750T3 DK99909670T DK99909670T DK1091750T3 DK 1091750 T3 DK1091750 T3 DK 1091750T3 DK 99909670 T DK99909670 T DK 99909670T DK 99909670 T DK99909670 T DK 99909670T DK 1091750 T3 DK1091750 T3 DK 1091750T3
Authority
DK
Denmark
Prior art keywords
cerebrospinal
vascular
preparation
pharmaceutical composition
cyclosporin
Prior art date
Application number
DK99909670T
Other languages
English (en)
Inventor
Marcus Keep
Eskil Elmer
Original Assignee
Maas Biolab Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maas Biolab Llc filed Critical Maas Biolab Llc
Application granted granted Critical
Publication of DK1091750T3 publication Critical patent/DK1091750T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99909670T 1999-02-26 1999-02-26 Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf DK1091750T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/004359 WO2000050058A1 (en) 1999-02-26 1999-02-26 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same

Publications (1)

Publication Number Publication Date
DK1091750T3 true DK1091750T3 (da) 2009-12-21

Family

ID=22272265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909670T DK1091750T3 (da) 1999-02-26 1999-02-26 Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf

Country Status (11)

Country Link
US (1) US7446093B1 (da)
EP (1) EP1091750B1 (da)
AT (1) ATE441425T1 (da)
AU (1) AU2882599A (da)
CA (1) CA2330329C (da)
CY (1) CY1109563T1 (da)
DE (1) DE69941359D1 (da)
DK (1) DK1091750T3 (da)
ES (1) ES2332390T3 (da)
PT (1) PT1091750E (da)
WO (1) WO2000050058A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370240A4 (en) * 2001-03-02 2004-09-22 Neuron Therapeutics Inc NEUROPROTECTOR FORMULATIONS AND METHOD
GB0329498D0 (en) * 2003-12-19 2004-01-28 Novartis Ag Organic compounds
US10123969B2 (en) 2015-10-15 2018-11-13 Wisconsin Alumni Research Foundation Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
CH679119A5 (da) * 1988-05-13 1991-12-31 Sandoz Ag
US5221607A (en) * 1989-09-18 1993-06-22 Scios Nova Inc. Assays and reagents for amyloid deposition
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5252463A (en) * 1990-06-22 1993-10-12 The Du Pont Merck Pharmaceutical Company Clipsin, a chymotrypsin-like protease and method of using same

Also Published As

Publication number Publication date
AU2882599A (en) 2000-09-14
DE69941359D1 (de) 2009-10-15
US7446093B1 (en) 2008-11-04
ATE441425T1 (de) 2009-09-15
CA2330329A1 (en) 2000-08-31
PT1091750E (pt) 2009-11-10
WO2000050058A1 (en) 2000-08-31
EP1091750A4 (en) 2005-04-13
EP1091750A1 (en) 2001-04-18
CY1109563T1 (el) 2014-08-13
ES2332390T3 (es) 2010-02-03
EP1091750B1 (en) 2009-09-02
CA2330329C (en) 2009-08-25

Similar Documents

Publication Publication Date Title
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
DK0914118T3 (da) Substituerede 3,5-diphenyl-1,2,4-triazoler og deres anvendelse som farmaceutiske metalkompleksdannere
IT1240765B (it) Composizioni farmaceutiche a base di ciclosporine.
IS4567A (is) Ný taxóíð, aðferð til að búa þau til og lyfjasamsetningar sem innihalda þau
DK1140993T3 (da) Glycopeptidderivater og farmaceutiske præparater indeholdende dem
NO2005009I2 (no) Emselex-darifenacin. Iupac-navn: (S)-2-ä1-Ä2-(2,3 -dihydrobenzofuran-5-yl)etylÜ-3-pyrrolidinylü-2,2-difenylacetamid
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
HRP20010277B1 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
NO985262L (no) Nye fosfonsyresubstituerte benzazepinon-N-edikksyrederivater, fremgangsmÕte for deres fremstilling, og legemidler inneholdende slike
DK1071433T3 (da) 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
DE69427286D1 (de) 7,42-bis (o-demethyl)rapamycin
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
NO971997D0 (no) Bruk av immunmodulerende midler
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
FR2763944B1 (fr) Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
FR2688118B1 (fr) Nouvelles compositions fongicides a base d'inhibiteurs de la biosynthese des sterols.
CY1109563T1 (el) Φαρμακευτικη συνθεση για εγκεφαλονωτιαια και αγγειακη εφαρμογη και μεθοδος για την παρασκευη της
NO990849L (no) Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner
IT8920405A0 (it) Aminoimidazopiridine farmacologicamente attive.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive